首页> 外文期刊>Clinical immunology: The official journal of the Clinical Immunology Society >The receptor for the globular 'heads' of C1q, gC1q-R, binds to fibrinogen/fibrin and impairs its polymerization.
【24h】

The receptor for the globular 'heads' of C1q, gC1q-R, binds to fibrinogen/fibrin and impairs its polymerization.

机译:C1q的球状“头部”受体gC1q-R与血纤蛋白原/血纤蛋白结合并损害其聚合。

获取原文
获取原文并翻译 | 示例
           

摘要

The 33-kDa cellular C1q binding protein, designated gC1q-R was previously shown to bind a number of plasma proteins involved in the coagulation and kinin systems. This study demonstrates the interaction between recombinant gC1q-R and fibrinogen. Using enzyme-linked immunosorbent assays, biotinylated gC1q-R was found to bind to microplate-immobilized fibrinogen in a manner which was specific and inhibited by excess soluble fibrinogen or polyclonal antibodies directed against either gC1q-R or fibrinogen. Moreover, gC1q-R inhibited fibrin polymerization in a dose-dependent manner. Reptilase induced fibrin clot formation was completely inhibited by gC1q-R at a 2:1 molar ratio (gC1q-R:fibrinogen), and repolymerization of thrombin induced fibrin monomers was similarly abrogated. At equivalent molar concentrations, gC1q-R appeared to be a more potent inhibitor of fibrin polymerization than fibrinogen, a well-known inhibitor. Moreover, in the presence of both gC1q-R and soluble fibrinogen, the effect of each inhibitor on fibrin polymerization was additive. When plasmin derived fibrinogen degradation products, including the C-terminal D domain (D-100) or the N-terminal E domain, were immobilized on microtiter plates, gC1q-R bound to fibrinogen fragment D-100, but not to fragment E. Further digestion of fibrinogen fragment D-100 by plasmin to fragment D-60 resulted in loss of gC1q-R binding. Thus, gC1q-R binds to the D domain of fibrinogen/fibrin, and the carboxyterminal segment of at least the fibrinogen/fibrin gamma chain appears important for this interaction. These observations may suggest a potential role for gC1q-R in modulating fibrin formation particularly at local sites of immune injury or inflammation. Copyright 1999 Academic Press.
机译:先前显示的33-kDa细胞C1q结合蛋白称为gC1q-R可以结合许多参与凝血和激肽系统的血浆蛋白。这项研究证明了重组gC1q-R和纤维蛋白原之间的相互作用。使用酶联免疫吸附测定法,发现生物素化的gC1q-R以固定的方式与微板固定的血纤蛋白原结合,并被过量的可溶性血纤蛋白原或针对gC1q-R或血纤蛋白原的多克隆抗体抑制。此外,gC1q-R以剂量依赖性方式抑制纤维蛋白聚合。爬虫酶诱导的血纤蛋白凝块形成被gC1q-R以2:1的摩尔比(gC1q-R:血纤蛋白原)完全抑制,凝血酶诱导的血纤蛋白单体的再聚合也被废止。在相同的摩尔浓度下,gC1q-R似乎是纤维蛋白聚合的有效抑制剂,而不是众所周知的纤维蛋白原。此外,在gC1q-R和可溶性纤维蛋白原同时存在的情况下,每种抑制剂对纤维蛋白聚合的影响是加和的。当纤溶酶衍生的纤维蛋白原降解产物(包括C端D结构域(D-100)或N端E结构域)固定在微量滴定板上时,gC1q-R会与纤维蛋白原片段D-100结合,但不会与E片段结合。纤溶酶进一步将纤维蛋白原片段D-100消化成D-60片段,导致gC1q-R结合丧失。因此,gC1q-R与血纤蛋白原/血纤蛋白的D结构域结合,并且至少血纤蛋白原/血纤蛋白γ链的羧基末端片段对于这种相互作用显得很重要。这些观察结果可能提示gC1q-R在调节血纤蛋白形成方面可能具有潜在作用,特别是在免疫损伤或炎症的局部部位。版权所有1999,学术出版社。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号